Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Gossamer Bio Inc GOSS

Healthcare Biotechnology
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH). Its product candidate Seralutinib, also known as GB002, is an investigational inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GOSS)

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire 8 days ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire November 11, 2024

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

Business Wire November 7, 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 7, 2024

Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024

Business Wire August 26, 2024

Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

Business Wire August 12, 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire June 7, 2024

Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference

Business Wire May 14, 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire May 10, 2024
View More News ››

Opinion & Analysis (NDAQ:GOSS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GOSS)

Gossamer Bio Announces Data Presentations at the European Re

News; $GOSS Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024- Additional Phase 2 TORREY Open...
whytestocks - August 26, 2024

Presenting on the Emerging Growth Conference 74 Day 2 on Aug

BREAKING NEWS: $GOSS Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register NowMIAMI, Aug. 21, 2024 (GLOBE NEWSWIRE...
whytestocks - August 21, 2024

Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying

NEWS: $GOSS Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying | BenzingaThe Dow Jones index closed higher by over 250 points...
whytestocks - June 25, 2024

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021

watching this one for

an entry point,it is really good to be on the sidelines looking at this one getting pounded down in its stock price but at some point it...
coolfooldumbguy - December 16, 2019
View more Bullboard ››

Star Diamond Corp

Star Diamond Corp

Star Diamond Corporation is a Canada-based company engaged in the acquisition, exploration and development of mineral ...
View More »